The GlucoBrain project uses advanced organ-on-chip technology to link the gut, pancreas, and brain, mapping how diabetes ...
GlucoBrain was established to help researchers understand exactly how diseases like diabetes and dementia work at a deeper, ...
A £500,000 GlucoBrain project will study how diabetes impacts brain function using a multi-organ chip linking the brain, gut, ...
A University of Bath-led project has secured £500,000 to develop a first-of-its-kind 'organ-on-chip' device that replicates ...
A newly published review article highlights the emerging importance of the immunoproteasome in the development and progression of diabetes and its wide-ranging complications, offering fresh ...
Bernstein 42nd Annual Strategic Decisions Conference May 28, 2026 1:30 PM EDTCompany ParticipantsDaniel Skovronsky - ...
New research shows a novel pill is helping people with advanced pancreatic cancer live longer. It's not a cure, as the drug's ...
A small clinical trial led by Dana-Farber Cancer Institute researchers has put a Salk Institute idea to the test in patients: ...
The new oral medication, daraxonrasib, has been shown to meaningfully extend the lives of patients with late-stage pancreatic cancer Getty Daraxonrasib targets a previously untreatable protein in ...
An experimental drug that could be a breakthrough in the treatment of one of the deadliest known cancers is driving demand at clinics while awaiting full government approval. Daraxonrasib, a drug that ...
Get unlimited access to ad-free articles and exclusive content. An AI model developed at the Mayo Clinic in Rochester, Minnesota, detected abnormalities on patients’ CT scans up to three years before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results